Xenotransplantation
The Engineered Pig Heart Beating in a Human Chest
In January 2022, surgeons placed a genetically modified pig heart into a living man — and for 40 days, it worked.
The Idea
Transplant medicine has always been constrained by the same brutal arithmetic: far more people need organs than donors can supply. Xenotransplantation — transplanting organs from one species into another — has been the tantalising answer to this problem for decades, perpetually on the horizon and perpetually falling short. The central obstacle is rejection: the human immune system is extraordinarily good at recognising what doesn't belong, and a pig organ triggers a response so ferocious it can destroy the transplanted tissue within minutes. What changed recently is CRISPR. Gene-editing tools now allow scientists to perform precise, targeted alterations to the pig genome — knocking out the pig genes that trigger human immune attack, inserting human genes that help the organ 'pass' as self, and removing retroviruses embedded in pig DNA that posed infection risks. The result isn't a pig organ dropped into a human body. It's something more like a bespoke biological object — an organ grown in a pig but designed, at the genetic level, with human compatibility in mind. The pigs used in current research carry anywhere from ten to over twenty genomic edits. What this reveals is something quietly profound: the boundary between species, at the molecular level, is far more negotiable than our intuitions suggest. Biology runs on shared infrastructure — the same proteins, the same cellular machinery — and with enough precision, we can redecorate the interior without replacing the architecture.
In the World
David Bennett Sr. was 57, had terminal heart disease, and was ineligible for a conventional transplant. In January 2022, at the University of Maryland Medical Center, he became the first person to receive a gene-edited pig heart as a permanent implant — not a bridge device, not an experiment on a brain-dead patient, but a last-resort attempt to keep a dying man alive. The heart came from a pig carrying ten specific genomic modifications developed by the biotechnology company Revivicor. Three pig genes linked to immune rejection had been deleted. A gene responsible for excessive cardiac growth had been removed. And six human genes had been inserted to help the organ integrate with Bennett's circulatory system. For the first few weeks, the results were extraordinary. The heart beat steadily. Bennett watched the Super Bowl. He did physical therapy. Then, around the five-week mark, the heart began to fail — likely due to a combination of immune factors and a latent pig virus detected in the tissue. He died two months after surgery. But the medical community's response wasn't defeat — it was calibration. The timeline was longer than any prior case, the failure points were now identified, and the path forward became clearer. In 2023 and 2024, surgeons at NYU Langone successfully transplanted gene-edited pig kidneys into brain-dead human patients and kept them functioning for extended observation periods — results that moved the field from proof-of-concept into something approaching early clinical science.
Why It Matters
The most immediate implication is logistical: the transplant waiting list is a quiet, ongoing catastrophe, and xenotransplantation is one of the few plausible routes out of it. If pig organs can be reliably engineered for human use, the supply constraint that kills thousands of people every year could be broken. But the deeper shift is conceptual. Xenotransplantation forces us to revisit what we mean by a 'human' body — and what level of biological intervention we're comfortable calling medicine versus something else. If a heart that kept you alive for decades was grown in a pig, is it your heart? These aren't merely philosophical puzzles. They will shape regulatory frameworks, insurance categories, and cultural attitudes toward the body in ways we haven't begun to work through. There's also the question of what we owe the animals involved. Pigs bred specifically for organ harvesting, engineered at the genome level for human benefit, exist in a moral category we don't yet have good language for. Sitting with this story means sitting with the fact that the future of medicine may be strange and genuinely difficult — and that is probably fine.
A Question to Ponder
If an organ can be engineered to cross the species boundary, what does that suggest about how we draw other biological boundaries — and which of those might be more permeable than we've assumed?
Get a new one of these every morning.
Start learning with Thinkable